Expertise in
1
conditions

Paul Girot

CHD Vendée
La Roche, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
CHD Vendée
La Roche, FR 

Overview

Paul Girot practices practicing medicine in La Roche, France.

Mr. Girot is highly rated in 1 condition, according to our data. His clinical expertise encompasses Insulinoma, Neuroendocrine Tumor, Platelet Storage Pool Deficiency, and Oculocutaneous Albinism Type 2.

He is actively involved in clinical research, co-authoring 18 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

CHD Vendée
La Roche, 85000, France
Other Locations
CHU Tours
Tours, 37000, France
1 Place Alexis Ricordeau, Nantes, 44093, France
Reims, France
Angers, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Enrollment Status: Recruiting
Publish Date: July 09, 2025
Intervention Type: Drug
Study Drugs: Oxaliplatin intravenous, 5 Fu, Folinic Acid, Oxaliplatin intra-arterial, Panitumumab, Bevacizumab
Study Phase: Phase 3
Randomized, Double-blind, Multicenter Placebo-controlled Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy
Randomized, Double-blind, Multicenter Placebo-controlled Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 02, 2025
Intervention Type: Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

18 Total Publications

Mild liver function decline in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma: a real-world study.
Mild liver function decline in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma: a real-world study.
Journal: European journal of gastroenterology & hepatology
Published: September 23, 2025

Frequently Asked Questions about Paul Girot

Is Paul Girot a top-rated expert for Insulinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Paul Girot is classified as an Advanced expert for Insulinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Paul Girot participate in research or clinical trials?

Yes. Paul Girot has published 18 articles and abstracts on conditions like Insulinoma. You can view a list of Paul Girot's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Girot's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile